Vident Investment Advisory’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-3,745
| Closed | -$213K | – | 1223 |
|
|
2021
Q2 | $213K | Buy |
+3,745
| New | +$213K | 0.01% | 1031 |
|
|
2020
Q1 | – | Sell |
-4,031
| Closed | -$291K | – | 845 |
|
|
2019
Q4 | $291K | Sell |
4,031
-106
| -3% | -$7.65K | 0.02% | 646 |
|
|
2019
Q3 | $580K | Buy |
4,137
+35
| +0.9% | +$4.91K | 0.05% | 290 |
|
|
2019
Q2 | $751K | Buy |
4,102
+297
| +8% | +$54.4K | 0.06% | 215 |
|
|
2019
Q1 | $605K | Buy |
3,805
+183
| +5% | +$29.1K | 0.03% | 511 |
|
|
2018
Q4 | $347K | Sell |
3,622
-230
| -6% | -$22K | 0.02% | 678 |
|
|
2018
Q3 | $544K | Sell |
3,852
-3,872
| -50% | -$547K | 0.02% | 658 |
|
|
2018
Q2 | $1.21M | Buy |
7,724
+961
| +14% | +$150K | 0.05% | 392 |
|
|
2018
Q1 | $1.1M | Buy |
+6,763
| New | +$1.1M | 0.04% | 377 |
|